[1]
|
陈佳佳, 范林骁, 李兰娟. 《肝衰竭诊治指南(2018版)》指南解读[J]. 中国临床医生杂志, 2020, 48(11): 1279-1282.
|
[2]
|
Rademacher, S., Oppert, M. and Jörres, A. (2011) Artificial Extracorporeal Liver Support Therapy in Patients with Severe Liver Failure. Expert Review of Gastroenterology & Hepatology, 5, 591-599. https://doi.org/10.1586/egh.11.59
|
[3]
|
邹龙, 等. 非生物型人工肝的治疗新进展[J]. 中国普外基础与临床杂志, 2017, 24(5): 634-637.
|
[4]
|
Di Campli, C., et al. (2005) Catholic University Experience with Molecular Adsorbent Recycling System in Patients with Severe Liver Failure. Transplantation Proceedings, 37, 2547-2550.
https://doi.org/10.1016/j.transproceed.2005.06.048
|
[5]
|
Kutsogiannis, D.J., et al. (2000) Regional Citrate Antico-agulation in Continuous Venovenous Hemodiafiltration. American Journal of Kidney Diseases, 35, 802-811. https://doi.org/10.1016/S0272-6386(00)70248-4
|
[6]
|
Morita, Y., et al. (1961) Regional Anticoagulation during Hemodialysis Using Citrate. The American Journal of the Medical Sciences, 242, 32-43. https://doi.org/10.1097/00000441-196107000-00005
|
[7]
|
Palsson, R. and Niles, J.L. (1999) Regional Citrate An-ticoagulation in Continuous Venovenous Hemofiltration in Critically Ill Patients with a High Risk of Bleeding. Kidney International, 55, 1991-1997.
https://doi.org/10.1046/j.1523-1755.1999.00444.x
|
[8]
|
Chappell, J.B. (1964) The Oxidation of Citrate, Isocitrate and Cis-Aconitate by Isolated Mitochondria. Biochemical Journal, 90, 225-237. https://doi.org/10.1042/bj0900225
|
[9]
|
龚德华. 枸橼酸三钠抗凝在血液净化中的应用[J]. 肾脏病与透析肾移植杂志, 2003(3): 286-289.
|
[10]
|
乐伟波, 龚德华. 枸橼酸的代谢动力学及其在连续性血液净化中的应用[J]. 肾脏病与透析肾移植杂志, 2009, 18(4): 363-366.
|
[11]
|
Shum, H.P., Yan, W.W. and Chan, T.M. (2014) Risks and Benefits of Citrate Anticoagulation for Continuous Renal Replacement Therapy. Hong Kong Medical Journal, 21, 149-154. https://doi.org/10.12809/hkmj144330
|
[12]
|
Khwaja, A. (2012) KDIGO Clinical Practice Guidelines for Acute Kid-ney Injury. Nephron Clinical Practice, 120, c179-c184. https://doi.org/10.1159/000339789
|
[13]
|
Tolwani, A. and Wille, K.M. (2012) Advances in Continuous Renal Replacement Therapy: Citrate Anticoagulation Update. Blood Purifi-cation, 34, 88-93. https://doi.org/10.1159/000342378
|
[14]
|
Slowinski, T., et al. (2015) Safety and Efficacy of Re-gional Citrate Anticoagulation in Continuous Venovenous Hemodialysis in the Presence of Liver Failure: The Liver Cit-rate Anticoagulation Threshold (L-CAT) Observational Study. Critical Care, 19, 349. https://doi.org/10.1186/s13054-015-1066-7
|
[15]
|
Qin, G., et al. (2014) Artificial Liver Support System Improves Short- and Long-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Single-Center Experience. Medicine (Baltimore), 93, e338.
https://doi.org/10.1097/MD.0000000000000338
|
[16]
|
Larsen, F.S., et al. (2016) High-Volume Plasma Exchange in Patients with Acute Liver Failure: An Open Randomised Controlled Trial. Journal of Hepatology, 64, 69-78. https://doi.org/10.1016/j.jhep.2015.08.018
|
[17]
|
Honore, P.M., et al. (2020) In Severe Liver Disease, Citrate Can Be Used Safely: The Question Remains—by Which Mechanism. Critical Care, 24, Article No. 63. https://doi.org/10.1186/s13054-020-2801-2
|
[18]
|
Honore, P.M., et al. (2019) Inducible Metabolic Pathway for Cit-rate Metabolism in Case of Major Liver Dysfunction: Fact or Fiction? Critical Care, 23, Article No. 166. https://doi.org/10.1186/s13054-019-2432-7
|
[19]
|
Sık, G., et al. (2020) Regional Citrate versus Systemic Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Children. The International Journal of Artifi-cial Organs, 43, 234-241.
https://doi.org/10.1177/0391398819893382
|
[20]
|
Lahmer, T., et al. (2015) Sustained Low-Efficiency Dialysis with Regional Citrate Anticoagulation in Medical Intensive Care Unit Patients with Liver Failure: A Prospective Study. Jour-nal of Critical Care, 30, 1096-1100.
https://doi.org/10.1016/j.jcrc.2015.06.006
|
[21]
|
单楠楠. 分析局部枸橼酸钠抗凝技术在重症监护病房(ICU)肝功能障碍患者连续静脉-静脉血液滤过(CVVH)中的安全性、有效性[J]. 中国医药指南, 2020, 18(16): 69-71.
|
[22]
|
章颖, 明芳, 薛红. 局部枸橼酸抗凝在肝衰竭患者连续性静脉-静脉血液滤过治疗中的应用[J]. 交通医学, 2021, 35(4): 380-383.
|
[23]
|
王临旭, 等. 局部枸橼酸抗凝在DPMAS联合低置换量血浆置换治疗慢加急性肝衰竭患者中的应用[J]. 现代生物医学进展, 2021, 21(14): 2748-2752, 2800.
|
[24]
|
Ma, Y., et al. (2019) Safety and Efficacy of Regional Citrate Anticoagulation during Plasma Adsorption plus Plasma Exchange Therapy for Patients with Acute-on-Chronic Liver Failure: A Pilot Study. Blood Purification, 48, 223-232.
https://doi.org/10.1159/000500408
|
[25]
|
中华医学会肝病学分会重型肝病与人工肝学组. 人工肝血液净化技术临床应用专家共识(2022年版) [J]. 临床肝胆病杂志, 2022, 38(4): 767-775.
|